MOLECULAR PARTNERS AG
MOLNCIK 0001745114
Revenue (TTM)
13.72M
−29.4% YoY
FY Dec 2025
Net Income (TTM)
−55.99M
−14.1% YoY
FY Dec 2025
EPS Diluted (TTM)
−1.65
−3.8% YoY
FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
-404.2%
FY Dec 2025
Net Margin
-408.0%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
82.65M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
40.37M sh
FY Dec 2025